Human Fibrinogen (FBG) ELISA Kit

$407.00

Catalog Number: EF2040-1

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
Product Size:96 Well Plate

Additional information

Format

Sandwich ELISA

Entrez Gene

2243, 2244, 2266

Components

Biotinylated Human Fibrinogen Antibody, Chromogen Substrate (1x), Human Fibrinogen Microplate, Human Fibrinogen Standard, MIX Diluent Concentrate (10x), Sealing Tapes, SP Conjugate (100x), Stop Solution (1x), Wash Buffer Concentrate (20x)

TIme

4 hours

Sensitivity

0.81 ng/ml

Range

1.25 – 80 ng/ml

Samples Type

CSF, Milk, Plasma, Saliva, Urine

Associated Disease

Blood Disorder, Cardiac

Species

Human

UniProt

P02671, P02675, P02679

Storage

Refer to component labels for details

Plex

1

Usage

For Research Use Only, Not To Be Used For Diagnostic Purposes

Documentation

Publications (38 results)

Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.

Association of nuts and whole grains intake, inflammation and the metabolic syndrome

  • http://arnmsmb.com/old/rjmms/rjmms/2013/55-63.pdf
  • SM El Shebini, MIA Moaty, NH Ahmed… - Res. J. Med. Med …, 2015 - arnmsmb.com
  • Background: Metabolic syndrome (MetS) is considered a proinflamatory and prothrombotic state. The measurement of inflammatory and prothrombotic markers might improve the …

Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute‐on‐chronic liver failure: an …

  • https://onlinelibrary.wiley.com/doi/abs/10.1111/liv.14034
  • M Premkumar, P Saxena, D Rangegowda… - Liver …, 2019 - Wiley Online Library
  • Background Patients with acute‐on‐chronic liver failure (ACLF) have coagulation failure in the setting of systemic inflammatory syndrome (SIRS), sepsis and extra‐hepatic organ failures…

Heparin-like effect associated with risk of bleeding, sepsis, and death in patients with severe alcohol-associated hepatitis

* Abolarin AT et al. (2022) Evaluating the effect of antidiabetic treatment on haemostatic and fibrinolytic parameters among type 2 diabetics in Ilorin, Nigeria. IBOM MEDICAL JOURNAL. 15(3): 252-258.

* Wang D et al. (2021) Activated factor X targeted stored in platelets as an effective gene therapy strategy for both hemophilia A and B. Clin Transl Med. 11(3):e375.

* Sozel H et al. (2021) Correlation of Serum Amyloid A in the Attack-Free Period with Other Inflammatory Markers in Adult Familial Mediterranean Fever Patients. Osmangazi Journal of Medicine. 43(6):609-616.

* Mostafa TM et al. (2021) The Effectiveness of 3 Combined Therapeutic Regimens in Egyptian Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Randomized Double-Blind Prospective Pilot Study. Curr Ther Res Clin Exp. 94:100625.

* Kimura K et al. (2021) Th1-CD11c+ B Cell Axis Associated with Response to Plasmapheresis in Multiple Sclerosis. Ann Neurol. 90(4):595-611.

* Khowal HK et al. (2021) Association of Serum Fibrinogen and Plasma VEGF Levels with Tumor Characteristics and Treatment Response in Operable Breast Carcinoma.

* Kamata K et al. (2021) In vitro blood compatibility evaluation method: incubating while rotating hemodialyzers filled with fresh human blood. J Artif Organs. 2020 Nov 16. doi: 10.1007/s10047-020-01224-6

* Premkumar M et al. (2019) Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute on chronic liver failure: An observational cohort study. Liver Int. 39(4):694-704

* ElShebiney SS et al. (2016) Multi-targeted therapy of hepatic fibrosis by adipose tissue derived mesenchymal stem cells. Int. J. Pharma. Cli. Research 8(7): 640-648.

* Ouyang Q et al. (2014) Effects of pristane alone or combined with chloroquine on macrophage activation, oxidative stress, and TH1/TH2 skewness. J Immunol Res. 2014:613136.

* Dowling P et al. (2014) Transferrin-bound proteins as potential biomarkers for advanced breast cancer patients.BBA Clinical. 2:24-30.

* Ou-Yang MC et al. (2013) Plasma Clusterin Concentrations May Predict Resistance to Intravenous Immunoglobulin in Patients with Kawasaki Disease. The Scientific World Journal. 2013: 382523, 5 pages

* Ekwere T et al. (2013) Assessment of some plasma fibrinolytic proteins in sickle cell anemia patients in steady state and in vaso-occlusive crises. Journal of Applied Hematology. 4(4):131-136

* Cerbone A et al. (2012) Rosiglitazone and AS601245 Decrease Cell Adhesion and Migration through Modulation of Specific Gene Expression in Human Colon Cancer Cells. PLoS One. 7(6):e40149

* Krysiak R and Okopien B (2011) Haemostatic effects of simvastatin in subjects with impaired glucose tolerance. Intern Med J. 41(6):473-481

* Akanji AO et al. (2011) Determinants of blood levels of some thrombogenic biomarkers in healthy Arab adolescent subjects. Clin Chem Lab Med. 49(10):1681-90

* Yu HR et al. (2010) Plasma clusterin levels in predicting the occurrence of coronary artery lesions in patients with Kawasaki disease. Pediatr Cardiol. 31(8):1151-6.

* Matvienko OA et al. (2010) Androidal Fat Dominates in Predicting Cardiometabolic Risk in Postmenopausal Women. Cardiol Res Pract. 2011:904878

* Yu HR et al. (2009) A unique plasma proteomic profiling with imbalanced fibrinogen cascade in patients with Kawasaki disease. Pediatr Allergy Immunol. 20(7):699-707.

* Lemmers A et al. (2009) An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease. Clin Exp Immunol. 156(3): 518-527

* Jindal R et al. (2009) Amino acid-mediated heterotypic interaction governs performance of a hepatic tissue model. FASEB J. 23(7):2288-2298

* Woodell-May J et al. (2008) Concentrated Plasma as a Carrier for Stem Cell Delivery. University of Southern California.

* Perry CD et al. (2008) Centrally located body fat is related to inflammatory markers in healthy postmenopausal women. Menopause 15(4):619-627

* Mohammed S et al. (2008) Methods of making concentrated fibrinogen containing compositions and associated systems for preparing fibrin glue. USPTO Patent Applicaton #: 20080267940

* Alston SM et al. (2008) In vivo efficacy of a new autologous fibrin sealant. J Surg Res. 146(1):143-148

* Sakai Y et al. (2007) Technique for the control of spheroid diameter using microfabricated chips. Acta Biomaterialia 3(6):1033-1040

* Cohen MJ et al. (2007) Early Coagulopathy After Traumatic Brain Injury: The Role of Hypoperfusion and the Protein C Pathway. J Trauma. 63(6):1254-1262

* Brohi K et al. (2007) Acute Traumatic Coagulopathy: Initiated by Hypoperfusion: Modulated Through the Protein C Pathway? Annals of Surgery 245(5):812-818

* Alston SM et al. (2007) New method to prepare autologous fibrin glue on demand. Transl Res. 149(4):187-95

* Fukuda J et al. (2005) Differentiation Effects by the Combination of Spheroid Formation and Sodium Butyrate Treatment in Human Hepatoblastoma Cell Line (Hep G2): A Possible Cell Source for Hybrid Artificial Liver. Cell Transplantation 14(10):819-827

* Alston SM Jr. (2005) Autologous fibrinogen purification and concentration for use in fibrin sealant. Ph.D. Dissertation, Department of Chemical Engineering, Brigham Young University

* Fukuda J et al. (2003) Efficacy of a Polyurethane Foam/Spheroid Artificial Liver by Using Human Hepatoblastoma Cell Line (Hep G2). Cell Transplantation 12(1):51-58

Loading data...